Meriter Hospital is a nonprofit hospital in Madison, Wisconsin, United States. It is operated by UnityPoint Health. A teaching hospital of the University of Wisconsin–Madison, it has 448 beds. The hospital, the fifth largest in the state, serves southern Wisconsin and northwestern Illinois.

During the past decade, Meriter Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meriter Hospital" #1 sponsor was "University of Wisconsin, Madison" with 10 trials, followed by "Boston Scientific Corporation" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Swallow Solutions" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meriter Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Akron Children's Hospital" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Meriter Hospital" are "Coronary Artery Disease" (3 trials), "Pregnancy" (2 trials), "Prostate Cancer" (2 trials), "Acute Kidney Injury" (1 trials) and "Atherosclerosis" (1 trials). Many other conditions were trialed in "Meriter Hospital" in a lesser frequency.

Most popular intervention types in "Meriter Hospital" are "Drug" (8 trials), "Other" (5 trials), "Device" (4 trials), "Procedure" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARRY-371797 (PF-07265803)" (1 trials), "Aspirin" (1 trials), "EGS Delirium Recovery Program" (1 trials), "Ferumoxytol" (1 trials) and "Group Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Meriter Hospital" are 9 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Meriter Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Meriter Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Meriter Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

Meriter Hospital has several departments that took part in Clinical trials: "Meriter Wisconsin Heart" - 4 trials